Concepedia

Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib

Lars-Arne Berger, Melanie Janning, Janna-Lisa Velthaus, Isabel Ben‐Batalla, Stefanie Schatz, Markus Falk, Peter Iglauer, Ronald Simon, Ru Cao, Claudio Forcato,

Journal of Thoracic Oncology · 2018 · 23 citations · 2 references

DOIFull text

Open access

Concepts

References

2

Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance

Hubing Shi, Gatien Moriceau, Xiangju Kong et al. · Nature Communications · 2012 · 620 citations · Full text

, , +14

Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer

Akihiro Kogita, Yosuke Togashi, Hidetoshi Hayashi et al. · International Journal of Oncology · 2014 · 50 citations · Full text

, , +16